fundamental hallmarks of breast cancer that drive tumor evolution, disease progression,
and therapeutic resistance. Understanding the mechanisms underlying these phenomena
is essential for improving cancer diagnosis, prognosis, and treatment strategies. Methods:
In this review, [...] Read more.
fundamental hallmarks of breast cancer that drive tumor evolution, disease progression,
and therapeutic resistance. Understanding the mechanisms underlying these phenomena
is essential for improving cancer diagnosis, prognosis, and treatment strategies. Methods:
In this review, we provide a comprehensive overview of the biological processes
contributing to CIN and CH, highlighting their molecular determinants and clinical
relevance. Results: We discuss the latest advances in detection methods, including singlecell
sequencing and other high-resolution techniques, which have enhanced our ability to
characterize intratumoral heterogeneity. Additionally, we explore how CIN and CH
influence treatment responses, their potential as therapeutic targets, and their role in
shaping the tumor immune microenvironment, which has implications for
immunotherapy effectiveness. Conclusions: By integrating recent findings, this review
underscores the impact of CIN and CH on breast cancer progression and their
translational implications for precision medicine. Full article